Biolog-id is awarded a contract with IPST funded by the European Commission for the use of Biolog-id Transfusion solution.
IPST, a recognized healthcare institution located in Portugal, decides to adopt the Biolog-id Transfusion solution following a tender awarded to Biolog-id in December 2023.